Search research articles
Contact Us
Filters
Showing results (91-100 of 136) with videos related to
Page
of 14
Sort By:
Journal of Affective Disorders
|
September 6, 2025
Sensitivity of the Patient-Health Questionnaire (PHQ-9) items to change in three clinical trials in low- and middle-income countries
Olawale F Ayilara, Alicia White, Gerard Dunleavy, et al.
Revue De Chirurgie Orthopedique Et Reparatrice De L'Appareil Moteur
|
July 25, 2007
[Magnetic resonance imaging of medial meniscus tears with displaced fragment in the meniscal recesses]
P Le Hir, C Charousset, L-D Duranthon, et al.
Journal of Clinical Psychopharmacology
|
June 1, 1997
Pulse-dosing and conventional application of doxepin: effects on psychopathology and hypothalamus-pituitary-adrenal (HPA) system
M Deuschle, J Schmider, B Weber, et al.
Diabetes & Metabolism
|
November 21, 2017
Morning administration of 0.4U/kg/day insulin glargine 300U/mL provides less fluctuating 24-hour pharmacodynamics and more even pharmacokinetic profiles compared with insulin degludec 100U/mL in type 1 diabetes
T S Bailey, J Pettus, R Roussel, et al.
Depression and Anxiety
|
October 24, 1998
Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment
I Heuser, G Bissette, M Dettling, et al.
Biodiversity Data Journal
|
February 5, 2024
Laevilacunaria (Mollusca, Gastropoda) in the Southern Ocean: A comprehensive occurrence dataset
Andreas Schmider-Martínez, Claudia S Maturana, Yarleth Poveda, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 8, 1999
O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressants
S M Fogelman, J Schmider, K Venkatakrishnan, et al.
Pharmacology
|
February 1, 1996
Characterization of six in vitro reactions mediated by human cytochrome P450: application to the testing of cytochrome P450-directed antibodies
J Schmider, D J Greenblatt, L L von Moltke, et al.
Molecular Psychiatry
|
April 24, 2001
Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia
R Kaiser, P B Tremblay, J Schmider, et al.
Psychopharmacology
|
October 21, 2000
Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatients
M Dettling, C Sachse, J Brockmöller, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 136) with videos related to
Sort By:
Page
of 14
Journal of Affective Disorders
|
September 6, 2025
Sensitivity of the Patient-Health Questionnaire (PHQ-9) items to change in three clinical trials in low- and middle-income countries
Olawale F Ayilara, Alicia White, Gerard Dunleavy, et al.
Revue De Chirurgie Orthopedique Et Reparatrice De L'Appareil Moteur
|
July 25, 2007
[Magnetic resonance imaging of medial meniscus tears with displaced fragment in the meniscal recesses]
P Le Hir, C Charousset, L-D Duranthon, et al.
Journal of Clinical Psychopharmacology
|
June 1, 1997
Pulse-dosing and conventional application of doxepin: effects on psychopathology and hypothalamus-pituitary-adrenal (HPA) system
M Deuschle, J Schmider, B Weber, et al.
Diabetes & Metabolism
|
November 21, 2017
Morning administration of 0.4U/kg/day insulin glargine 300U/mL provides less fluctuating 24-hour pharmacodynamics and more even pharmacokinetic profiles compared with insulin degludec 100U/mL in type 1 diabetes
T S Bailey, J Pettus, R Roussel, et al.
Depression and Anxiety
|
October 24, 1998
Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment
I Heuser, G Bissette, M Dettling, et al.
Biodiversity Data Journal
|
February 5, 2024
Laevilacunaria (Mollusca, Gastropoda) in the Southern Ocean: A comprehensive occurrence dataset
Andreas Schmider-Martínez, Claudia S Maturana, Yarleth Poveda, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 8, 1999
O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressants
S M Fogelman, J Schmider, K Venkatakrishnan, et al.
Pharmacology
|
February 1, 1996
Characterization of six in vitro reactions mediated by human cytochrome P450: application to the testing of cytochrome P450-directed antibodies
J Schmider, D J Greenblatt, L L von Moltke, et al.
Molecular Psychiatry
|
April 24, 2001
Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia
R Kaiser, P B Tremblay, J Schmider, et al.
Psychopharmacology
|
October 21, 2000
Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatients
M Dettling, C Sachse, J Brockmöller, et al.
Page
of 14